Bevacizumab and haemoglobin decreased Patient Reports February 10, 2012

Bevacizumab Side Effects Report #6014991-9
Bevacizumab side effect was reported by a Health Professional from UNITED KINGDOM on May 22, 2006. Female patient, 75 years of age, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ascites, disease progression, dyspepsia, haemoglobin decreased, peritoneal haemorrhage. Bevacizumab dosage: 5 MG/M2, UNK. Patient died on 12/28/2005.

Bevacizumab Side Effects Report #6038904-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 14, 2009. Male patient, weighting 174.2 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: clostridium bacteraemia, fatigue, haemoglobin decreased, hypercalcaemia. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5550710-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 29, 2007. Female patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL, TAKEPRON, AROTINOLOL HYDROCHLORIDE, ASPARA K, PREDONINE, LASIX. Patient recovered.

Bevacizumab Side Effects Report #5582173-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 25, 2007. Female patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL, TAKEPRON, AROTINOLOL HYDROCHLORIDE, ASPARA K, PREDONINE, LASIX. Patient recovered.


Bevacizumab Side Effects Report #5773105-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 02, 2008. Female patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL, LANSOPRAZOLE, AROTINOLOL HYDROCHLORIDE, ASPARA K, PREDONINE, LASIX. Patient recovered.

Bevacizumab Side Effects Report #5948713-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 28, 2008. Male patient, weighting 114.6 lb, was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: enterocolitis, haemoglobin decreased, interstitial lung disease. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE, OXALIPLATIN, LEVOLEUCOVORIN CALCIUM, FLUOROURACIL, WARFARIN. Patient recovered.

Bevacizumab Side Effects Report #5223438-1
Bevacizumab side effect was reported by a Physician from FRANCE on Jan 22, 2007. Female patient, 37 years of age, weighting 112.4 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, subileus. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5102968-7
Bevacizumab side effect was reported by a Health Professional from FRANCE on Aug 23, 2006. Female patient, 37 years of age, weighting 112.4 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, subileus. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6039333-4
Bevacizumab side effect was reported by a Health Professional from UNITED KINGDOM on Jan 05, 2009. Female patient, 67 years of age, was diagnosed with pancreatic carcinoma, rheumatoid arthritis  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastric mucosal lesion, gastric ulcer, gastrointestinal haemorrhage, haemoglobin decreased, recall phenomenon, thrombocytopenia, uterine atrophy, vaginal haemorrhage. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, GEMCITABINE, INFLIXIMAB. Patient recovered.


Bevacizumab Side Effects Report #5347633-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 04, 2007. Male patient, 49 years of age, weighting 164.0 lb, was diagnosed with pancreatic carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: amnesia, blood glucose increased, blood pressure decreased, electrocardiogram t wave inversion, haematemesis, haematocrit decreased, haemoglobin decreased, loss of consciousness, nausea . Bevacizumab dosage: 745 MG EVERY 14 DAYS IV. During the same period patient was treated with OXYCODONE EXTENDED, NEXIUM, REGLAN, SENOKOT, CREON, PHENERGAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5747665-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 08, 2008. Female patient, weighting 121.3 lb, was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, dizziness , fatigue, haemoglobin decreased, hypokalaemia, neuropathy peripheral, thrombocytopenia, tinnitus . Bevacizumab dosage: 412.5 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5751407-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 14, 2008. Female patient, weighting 121.3 lb, was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium decreased, fatigue, haemoglobin decreased, hypokalaemia, peripheral sensory neuropathy, thrombocytopenia. Bevacizumab dosage: 412.5 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4780308-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 09, 2005. Female patient, 59 years of age, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium abnormal, blood phosphorus decreased, cerebral infarction, chest x-ray abnormal, convulsion, haematocrit decreased, haemoglobin decreased, heart rate increased, hydronephrosis. Bevacizumab dosage: 825 MG, Q3W, INTRAVENOUS. Patient was hospitalized. Patient died on 08/02/2005.

Bevacizumab Side Effects Report #4780314-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 09, 2005. Female patient, 59 years of age, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium increased, blood phosphorus decreased, contrast media reaction, convulsion, disease progression, haematocrit decreased, haemoglobin decreased, heart rate increased. Bevacizumab dosage: 825 MG, Q3W, INTRAVENOUS. During the same period patient was treated with NIFEDIPINE, PAXIL, NEUTRA, MAGNESIUM SULPHATE, LACTULOSE, MEGACE, PRILOSEC, CIPROFLOXACIN. Patient was hospitalized. Patient died on 08/02/2005.


Bevacizumab Side Effects Report #5887075-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 09, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, haemoglobin decreased, neutropenia, renal failure acute, syncope vasovagal. Bevacizumab dosage: unknown. During the same period patient was treated with TAXOL, CISPLATIN, ACETAMINOFEN, APREPITANT, ATORVASTATIN CALCIUM, DEXAMETHASONE, DOCUSATE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5300838-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Male patient, 75 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer, bone marrow failure and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, cough, decubitus ulcer, deep vein thrombosis , diarrhoea, haemoglobin decreased, hyperhidrosis, lung infiltration, oxygen saturation decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOTERE, OXALIPLATIN, DILAUDID, FILGRASTIM, DURAGESIC, TUSSINEX, PHENERGAN, HYCODAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4964455-6
Bevacizumab side effect was reported by a Physician from POLAND on Mar 15, 2006. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, cold agglutinins positive, coombs test positive, epistaxis, haemoglobin decreased, white blood cell count decreased. Bevacizumab dosage: 7.5 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5847419-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 01, 2008. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, oesophagitis. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with VINORELBINE, CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4981262-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 12, 2005. Female patient, 46 years of age, weighting 209.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, duodenal perforation, escherichia urinary tract infection, haemoglobin decreased, ileus, lung neoplasm, pancreatic cyst. Bevacizumab dosage: 1418 MG, Q3W, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, LIPITOR, LASIX, COREG, PRINIVIL, POTASSIUM CHLORIDE, AMPICILLIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5376412-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 22, 2007. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anxiety , blood urea decreased, computerised tomogram abnormal, dysphagia, eructation, haematocrit decreased, haemoglobin decreased, hypovolaemia, lung neoplasm malignant. Bevacizumab dosage: 10 MG/KG, QOW. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5468893-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 11, 2007. Male patient, weighting 163.4 lb, was diagnosed with non-small cell lung cancer, hypertension, chronic obstructive pulmonary disease, iron deficiency, musculoskeletal chest pain and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, bacterial sepsis, blood creatinine decreased, chest discomfort, haemoglobin decreased, hepatic cirrhosis. Bevacizumab dosage: 1110 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, LOTENSIN, ADVAIR DISKUS, ALBUTEROL, NORVASC, FEOSOL, VICODIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5717778-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 17, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blepharitis, blood albumin decreased, confusional state, haemoglobin decreased, hypocalcaemia, hypokalaemia, platelet count decreased. Bevacizumab dosage: 960 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMZAR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5754298-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 16, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, haemoglobin decreased. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5759299-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 16, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory failure, dehydration, haemoglobin decreased. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 10/05/2007.


Bevacizumab Side Effects Report #5847174-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 01, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, haemoglobin decreased, hypoxia, pneumonitis. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with TAXOTERE, DEXAMETHASONE, NEUPOGEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5875646-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 25, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased. Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 10/05/2007.

Bevacizumab Side Effects Report #5929928-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased, hypoproteinaemia, pneumonia . Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 10/05/2007.

Bevacizumab Side Effects Report #5944151-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased, hypoproteinaemia, pneumonia . Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6072691-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 02, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, haemoglobin decreased, thrombosis, vomiting. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #4961873-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 22, 2006. Male patient, 52 years of age, weighting 224.9 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacteria urine identified, band neutrophil percentage increased, blood chloride decreased, blood sodium decreased, face oedema, haemoglobin decreased, lymphocyte percentage decreased, petechiae. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, ERLOTINIB, STEROID NOS, PROTONIX, OXYCONTIN, OXYCODONE, MIRALAX, ZOFRAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5998026-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with VORINOSTAT. Patient recovered.

Bevacizumab Side Effects Report #4887657-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2006. Female patient, 71 years of age, weighting 126.1 lb, was diagnosed with mesothelioma  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, chest pain , dehydration, gastrointestinal haemorrhage, haemoglobin decreased, oedema peripheral, thrombosis. Bevacizumab dosage: 858 MG ., QD/DAYS IV. During the same period patient was treated with TARCEVA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5289245-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 03, 2007. Male patient, 72 years of age, weighting 168.0 lb, was diagnosed with lung neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, haemoptysis. Bevacizumab dosage: 1100 MG ONCE IV DRIP. Patient died on 03/23/2007.

Bevacizumab Side Effects Report #5418291-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2007. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ascites, gastrointestinal haemorrhage, haemoglobin decreased, oedema peripheral. Bevacizumab dosage: 10 MG/M2, Q2W. During the same period patient was treated with ERLOTINIB, ACIPHEX, ACTOS, ALTACE, IMODIUM. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5448059-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 05, 2007. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ascites, gastrointestinal haemorrhage, haemoglobin decreased, oedema peripheral. Bevacizumab dosage: 10 MG/M2, Q2W. During the same period patient was treated with ERLOTINIB, ACIPHEX, ACTOS, ALTACE, IMODIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5265812-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, 68 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, haematochezia, haemoglobin decreased, mental status changes, neuropathy, oral intake reduced, prothrombin time abnormal, sedation. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, TIMOLOL MALEATE, NEXIUM, COUMADIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5283507-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Female patient, 68 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: glioblastoma multiforme, haematochezia, haemoglobin decreased, malignant neoplasm progression, peripheral motor neuropathy, sedation. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, TIMOLOL MALEATE, NEXIUM, COUMADIN, DEXAMETHASONE. Patient was hospitalized. Patient died on 03/18/2007.

Bevacizumab Side Effects Report #5133976-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 02, 2006. Male patient, 59 years of age, weighting 222.0 lb, was diagnosed with glioblastoma multiforme, oedema and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, blood glucose increased, blood sodium decreased, disease progression, electromechanical dissociation, haematocrit decreased, haemoglobin decreased, hypoxia, lobar pneumonia. Bevacizumab dosage: 977 MG, Q2W, INTRAVENOUS. During the same period patient was treated with DECADRON, KEPPRA, PRAVASTATIN, PEPCID, EFFEXOR. Patient was hospitalized. Patient died on 10/04/2006.

Bevacizumab Side Effects Report #4799983-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2005. Male patient, 69 years of age, weighting 194.3 lb, was diagnosed with gastrooesophageal cancer, metastasis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fall , fatigue, haemoglobin decreased. Bevacizumab dosage: 15MG/KG IV EVERY 21 DAY. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, FERROUS SULPHATE, MOTRIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5531769-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 21, 2007. Female patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hyperglycaemia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with ERLOTINIB, MORPHINE, MEGACE, PANTOPRAZOLE, IMODIUM, BRUFEN, MYCOSTATIN, IMOZOP. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5573593-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 11, 2007. Female patient was diagnosed with gastrointestinal carcinoma, dyspepsia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, hyperglycaemia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with ERLOTINIB, MORPHINE, MEGACE, PANTOLOC, IMODIUM, BRUFEN, MYCOSTATIN, IMOZOP. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5580924-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 19, 2007. Female patient was diagnosed with gastrointestinal carcinoma, dyspepsia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, haemoglobin decreased, hyperglycaemia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with ERLOTINIB, MORPHINE, MEGACE, PANTOLOC, IMODIUM, BRUFEN, MYCOSTATIN, IMOZOP. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5594060-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 02, 2008. Female patient was diagnosed with gastrointestinal carcinoma, dyspepsia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, haemoglobin decreased, hyperglycaemia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with ERLOTINIB, MORPHINE, MEGACE, PANTOLOC, IMODIUM, BRUFEN, MYCOSTATIN, IMOZOP. Patient was hospitalized. Patient died on 11/21/2007.

Bevacizumab Side Effects Report #5607055-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 14, 2008. Female patient was diagnosed with gastrointestinal carcinoma, dyspepsia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, haemoglobin decreased, hyperglycaemia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with ERLOTINIB, MORPHINE, MEGACE, PANTOLOC, IMODIUM, BRUFEN, MYCOSTATIN, IMOZOP. Patient was hospitalized. Patient died on 11/21/2007.

Bevacizumab Side Effects Report #5162258-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 14, 2006. Male patient, 73 years of age, weighting 183.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastroenteritis , haematocrit decreased, haemoglobin decreased. Bevacizumab dosage: 465MG IV Q 14 DAYS. During the same period patient was treated with FLUOROURACIL, CORTISONE ACETATE, FLUDRACORT, COUMADIN, CIPRO, PROSCAR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5193680-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 06, 2006. Male patient, 73 years of age, weighting 183.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: adhesion , blood potassium decreased, haematocrit decreased, haemoglobin decreased, peritoneal neoplasm, small intestinal obstruction, white blood cell count decreased. Bevacizumab dosage: 465MG IV Q 14 DAYS. During the same period patient was treated with FLUOROURACIL, CORTISONE ACETATE, FLUDRACORT, COUMADIN, CIPRO, PROSCAR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4698725-6
Bevacizumab side effect was reported by a Health Professional from on June 09, 2005. Female patient, 67 years of age, weighting 164.0 lb, was diagnosed with colorectal cancer metastatic, colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , haemoglobin decreased, lymphocyte count increased, neutropenia, pelvic abscess, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN, ZOCOR, PROPOLIS, VITAMIN, VITAMIN C. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5503221-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 17, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aplasia, haemoglobin decreased, pyrexia. Bevacizumab dosage: 234 MG, Q3W. During the same period patient was treated with IRINOTECAN, CAPECITABINE, CLINOMEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5405130-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 19, 2007. Male patient was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood pressure decreased, enteritis infectious, haemoglobin decreased, peritonitis, platelet count decreased, red blood cell count decreased, weight increased. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5789445-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 18, 2008. Male patient, 67 years of age, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, gastroenteritis , haematocrit decreased, haemoglobin decreased, hyponatraemia, oral intake reduced, somnolence. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, MORPHINE, LIPITOR, PROCHLORPERAZINE, DIGOXIN, SENNA, RANITIDINE, ASPIRIN. Patient died on 09/25/2007.

Bevacizumab Side Effects Report #5325629-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 03, 2007. Male patient, weighting 170.2 lb, was diagnosed with colon cancer, infection  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cellulitis , deep vein thrombosis , gastric haemorrhage, haematemesis, haemoglobin decreased, infection , no therapeutic response, oesophageal ulcer, ulcer haemorrhage. Bevacizumab dosage: 575 MG, Q3W. During the same period patient was treated with CAPECITABINE, FUSIDATE, VANCOMYCIN, OMEPRAZOLE, FLUCLOXACILLINE, PARACETAMOL, VITAMIN K, IMIPENEM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6110450-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 02, 2009. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, large intestinal ulcer, rectal haemorrhage. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4765871-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 08, 2005. Male patient, weighting 166.0 lb, was diagnosed with colon cancer, metastases to liver and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute myocardial infarction, haematocrit decreased, haemoglobin decreased. Bevacizumab dosage: 7.5MG/KG Q3 WEEKS. During the same period patient was treated with CAPECITABINE, GLUCOVANCE, CARDURA, PROSCAR, COENZYME Q. Patient recovered.

Bevacizumab Side Effects Report #5226026-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 23, 2007. Female patient, 66 years of age, weighting 220.9 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cellulitis , cellulitis staphylococcal, condition aggravated, haematocrit decreased, haemoglobin decreased, oedema peripheral, pseudomonas infection, purulence, ulcer . Bevacizumab dosage: 1590 MG, Q3W, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, CALCIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5259969-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 23, 2007. Female patient, 66 years of age, weighting 220.9 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood pressure increased, cellulitis , culture wound positive, diphtheria , haematocrit decreased, haemoglobin decreased, heart rate increased, pseudomonas infection, purulent discharge. Bevacizumab dosage: 1590 MG, Q3W, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, CALCIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5194459-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 15, 2006. Female patient, 62 years of age, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood alkaline phosphatase increased, dehydration, escherichia bacteraemia, fall , haemoglobin decreased, head injury, renal failure, sepsis syndrome. Bevacizumab dosage: 10 MG/KG, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, RAMIPRIL, VICODIN, DURAGESIC, MACROBID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5440555-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 20, 2007. Female patient was diagnosed with breast cancer metastatic, colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood phosphorus decreased, diarrhoea, haematocrit decreased, haemoglobin decreased, mucosal inflammation, red blood cell count decreased. Bevacizumab dosage: unknown. During the same period patient was treated with ABRAXANE, NEUPOGEN. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5545673-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 06, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood alkaline phosphatase increased, dehydration, disease recurrence, escherichia sepsis, fall , haemoglobin decreased, head injury, renal failure. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PACLITAXEL, RAMIPRIL, VICODIN, DURAGESIC, MACROBID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5633937-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 07, 2008. Female patient, weighting 119.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Bevacizumab dosage: 900 MG, 3/WEEK. During the same period patient was treated with TAXOTERE, CAPECITABINE, BENADON, CHLORPROMAZINE, DEROXAT, PANTOZOL, PASPERTIN. Patient recovered.


Bevacizumab Side Effects Report #5830444-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 18, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: catheter site inflammation, haemoglobin decreased, impaired healing, platelet count increased, red blood cell count decreased. Bevacizumab dosage: 10 MG/KG, Q2W. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5261561-6
Bevacizumab side effect was reported by a Health Professional from CANADA on Feb 20, 2007. Female patient, 65 years of age, weighting 195.1 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, diarrhoea, haemoglobin decreased, intestinal ischaemia, po2 decreased, rectal haemorrhage, tachyarrhythmia. Bevacizumab dosage: 7.5 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with TYLENOL, METOPROLOL TARTRATE, ALLOPURINOL, DECADRON, METFORMIN, ARANESP, PAMIDRONATE. Patient died on 11/02/2006.

Bevacizumab Side Effects Report #5547342-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2007. Female patient, weighting 158.0 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atelectasis, deep vein thrombosis , dyspnoea, groin abscess, haemoglobin decreased, sepsis , ulcer . Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, PROTONIX, WELLBUTRIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5547348-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2007. Female patient, weighting 158.0 lb, was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atelectasis, blood culture positive, deep vein thrombosis , dyspnoea, groin abscess, haemoglobin decreased, perineal abscess, sepsis . Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, PROTONIX, WELLBUTRIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5990522-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with VORINOSTAT, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6014754-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 12, 2008. Female patient was diagnosed with breast cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with VORINOSTAT, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6132282-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 17, 2009. Female patient, weighting 240.1 lb, was diagnosed with breast cancer , sinusitis  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: adrenal disorder, atelectasis, candidiasis, chills, diarrhoea, dyspnoea exertional, haemoglobin decreased, hepatic steatosis, leukocytosis. Bevacizumab dosage: 1123 MG, UNK. During the same period patient was treated with ABRAXANE, CYCLOPHOSPHAMIDE, ADRIAMYCIN RDF, NEULASTA, MOXIFLOXACIN, COMPAZINE, COUMADIN, ZANTAC. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5953350-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 07, 2008. Male patient, 65 years of age, weighting 172.0 lb, was diagnosed with bladder cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, escherichia urinary tract infection, haemoglobin decreased, platelet count decreased, pyrexia, syncope. Bevacizumab dosage: 1217 MG, Q21D. During the same period patient was treated with CISPLATIN, GEMZAR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5724869-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2008. Female patient, weighting 110.2 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: ascites, gastrointestinal anastomotic leak, haemoglobin decreased, intestinal obstruction, intra-abdominal haemorrhage, neuropathy peripheral, post procedural complication, retroperitoneal haemorrhage. Bevacizumab dosage: 508 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL, HYDROCLORATHIAZIDE, RAMIPRAL. Patient was hospitalized. Patient recovered.